Procter & Gamble insider filing: 189-share director grant reported
Rhea-AI Filing Summary
Ashley McEvoy, a director of Procter & Gamble Co (PG), was awarded 189 shares of Common Stock on 09/09/2025 under The Procter & Gamble 2019 Stock and Incentive Compensation Plan. The grant carries a $0 per-share transaction price and the total post-transaction beneficial ownership is reported as 3,843.0241 shares, which the filer says includes dividend equivalents issued as Restricted Stock Units. The Form 4 was signed by an attorney-in-fact on 09/10/2025. The filing discloses a routine equity award to a director as part of compensation; no sale or cash purchase occurred.
Positive
- Grant of 189 shares to a director under the company's 2019 Stock and Incentive Compensation Plan, reflecting standard governance-aligned compensation
- Post-transaction beneficial ownership disclosed (3,843.0241 shares), including dividend equivalents, improving transparency
Negative
- None.
Insights
TL;DR: A routine director equity award was granted; disclosure aligns with standard compensation practices.
This Form 4 shows a non-derivative grant of 189 shares at $0 under the company's 2019 Stock and Incentive Compensation Plan. The filing states the total beneficial ownership of the reporting person now equals 3,843.0241 shares, including dividend-equivalent RSUs. For governance review, this appears to be a standard compensation-related issuance to a director rather than a transaction indicating insider trading or change in intent. The reporting was executed via attorney-in-fact, and the form includes the required signature and explanation notes.
TL;DR: The transaction is immaterial to company valuation and reflects routine equity compensation.
The entry records an award (code A) of 189 common shares with a $0 reported price, consistent with compensation or RSU settlement practices. The disclosure clarifies inclusion of dividend equivalents. There is no sale, pledge, or exercise activity reported. From a market-impact perspective, the size and nature of the grant are unlikely to be material to investors.